Applicant	Tradename	Generic Name	NDA	Approval Date	Type	RLD	Patent Number	Patent Expiration	Exclusivity Expiration
Roche	BONIVA	ibandronate sodium	021455	Mar 24, 2005	RX	Yes			MAR 24,2008
Roche	BONIVA	ibandronate sodium	021455	Mar 24, 2005	RX	Yes			MAY 16,2008
Roche	BONIVA	ibandronate sodium	021455	Mar 24, 2005	RX	Yes	4,927,814	JUL 09,2007

Export available with Ultimate Plan subscription:

This preview shows a limited data set. Complete access is available with a Subscription

Paragraph IV activity for: BONIVA

Drugname	Dosage	Strength	RLD	Submissiondate
ibandronate sodium	Injection	1 mg/mL, 3 mL Vial	Boniva	8/31/2007
ibandronate sodium	Tablets	2.5 mg and 150 mg	Boniva	5/16/2007

<- Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Follow DrugPatentWatch on Twitter

Bookmark or Share This Page ...